Treat, Prevent, Restore: Sensorion’s Approach To Hearing Loss

French Biotech Is Developing Small Molecules And Gene Therapies

Hearing loss lacks pharmacological treatment options, with patients instead relying on medical devices or going untreated. In Vivo spoke to French biotech Sensorion, which is targeting a number of hearing loss indications with small-molecule drugs and gene therapies.

Adult woman and young girl conversing in sign language at a playground
• Source: Shutterstock

More from Innovation

More from In Vivo